AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26141379 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine hCG application (younger group <38 years)
Number of subjects: 1186
Study 26141379 — intervention group
Group type: COMPARATOR
Intervention: Control group (younger group <38 years)
Number of subjects: 1186
Study 26141379 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine hCG application (older group ≥38 years)
Number of subjects: 1186
Study 26141379 — intervention group
Group type: COMPARATOR
Intervention: Control group (older group ≥38 years)
Number of subjects: 1186
Study 23651767 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based alcohol interventions
Number of subjects: 0
Study 23651767 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 21491994 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral clonidine (5 μg/kg)
Number of subjects: 62
Study 21491994 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 tablet)
Number of subjects: 62
Study 19922618 — intervention group
Group type: COMPARATOR
Intervention: Client information leaflet control condition (n = 32 OMs)
Number of subjects: 480
Study 19922618 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute simple structured advice (n = 32 OMs)
Number of subjects: 480
Study 19922618 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-minute brief lifestyle counselling delivered by an Alcohol Health Worker (n = 32 OMs)
Number of subjects: 480
Study 16513449 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomelo juice with cyclosporine
Number of subjects: 12
Study 16513449 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry juice with cyclosporine
Number of subjects: 12
Study 16513449 — intervention group
Group type: COMPARATOR
Intervention: Water with cyclosporine
Number of subjects: 12
Study 15299059 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F‐FDG PET/CT
Number of subjects: 20
Study 15299059 — intervention group
Group type: COMPARATOR
Intervention: (18)F‐FDG PET alone
Number of subjects: 20
Study 11228210 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human FSH (r‐hFSH) 150 IU/day
Number of subjects: 50
Study 11228210 — intervention group
Group type: EXPERIMENTAL
Intervention: highly purified urinary FSH (u‐hFSH HP) 150 IU/day
Number of subjects: 50
Study 11228210 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal ovulation women)
Number of subjects: 50
Study 11228210 — intervention group
Group type: EXPERIMENTAL
Intervention: Both r‐hFSH and u‐hFSH
Number of subjects: 50
Study 9347380 — intervention group
Group type: EXPERIMENTAL
Intervention: Mianserin (n = 13)
Number of subjects: 38
Study 9347380 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone (n = 12)
Number of subjects: 38
Study 9347380 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 38
Study 8102399 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine (30 mg/kg/day, max 2 g/day)
Number of subjects: 56
Study 8102399 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine (60 mg/kg/day, max 4 g/day)
Number of subjects: 56
Study 8102399 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine
Number of subjects: 56
Study 8102399 — intervention group
Group type: COMPARATOR
Intervention: Sulfasalazine
Number of subjects: 56
Study 2967028 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol 50 mg
Number of subjects: 10
Study 2967028 — intervention group
Group type: EXPERIMENTAL
Intervention: acebutolol 200 mg
Number of subjects: 10
Study 29719884 — intervention group
Group type: EXPERIMENTAL
Intervention: Software-directed medication history
Number of subjects: 209
Study 29719884 — intervention group
Group type: COMPARATOR
Intervention: Paper-based medication history
Number of subjects: 209
Study 29719884 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 209
Study 28594615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth-brushing with concurrent suctioning technique
Number of subjects: 0
Study 28594615 — intervention group
Group type: COMPARATOR
Intervention: Mouth-swabbing
Number of subjects: 0
Study 26563599 — intervention group
Group type: EXPERIMENTAL
Intervention: 4th Edition Second Step® program combined with brief training on proactive classroom management
Number of subjects: 7300
Study 26563599 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 7300
Study 23507561 — intervention group
Group type: EXPERIMENTAL
Intervention: WebChoice eHealth application
Number of subjects: 103
Study 21508856 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2140023 monohydrate 5 mg twice daily
Number of subjects: 0
Study 21508856 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2140023 monohydrate 20 mg twice daily
Number of subjects: 0
Study 21508856 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2140023 monohydrate 40 mg twice daily
Number of subjects: 0
Study 21508856 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2140023 monohydrate 80 mg twice daily
Number of subjects: 0
Study 21508856 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 0
Study 21508856 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (am) and 15 mg of olanzapine (pm) daily
Number of subjects: 0
Study 19620593 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal speech (ES)
Number of subjects: 49
Study 19620593 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrolaryngeal speech (EL)
Number of subjects: 49
Study 19620593 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic device speech (PD)
Number of subjects: 49
Study 19620593 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheoesophageal speech (TE)
Number of subjects: 49
Study 17380807 — intervention group
Group type: EXPERIMENTAL
Intervention: Metallic matrix and wooden wedge
Number of subjects: 23
Study 17380807 — intervention group
Group type: COMPARATOR
Intervention: Polyester matrix and reflexive wedge
Number of subjects: 23
Study 15067584 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11903414 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 110
Study 11903414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine H2-receptor antagonists in conventional dosages
Number of subjects: 0
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Prokinetic agents
Number of subjects: 0
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 0
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole and lansoprazole
Number of subjects: 0
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy
Number of subjects: 0
Study 9012279 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 7951199 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive imagery
Number of subjects: 0
Study 7951199 — intervention group
Group type: COMPARATOR
Intervention: Separate imagery
Number of subjects: 0
Study 7951199 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of BEER and 'alcoholic beverages' before study
Number of subjects: 0
Study 7951199 — intervention group
Group type: EXPERIMENTAL
Intervention: Presentation of DOG and BEER
Number of subjects: 0
Study 3301166 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin treatment before feeding
Number of subjects: 6
Study 3301166 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding
Number of subjects: 6
Study 3301166 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (oral dose 2h before measurement)
Number of subjects: 6
Study 3301166 — intervention group
Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 6
Study 3301166 — intervention group
Group type: COMPARATOR
Intervention: Fed state
Number of subjects: 6
Study 31810563 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmented Le Fort I osteotomy with alar cinch technique
Number of subjects: 80
Study 31810563 — intervention group
Group type: COMPARATOR
Intervention: Non-segmented Le Fort I osteotomy with alar cinch technique
Number of subjects: 80
Study 29127910 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐d‐mannuronic acid
Number of subjects: 85
Study 29127910 — intervention group
Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 85
Study 29127910 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 85
Study 26202487 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBV)
Number of subjects: 26
Study 25633207 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Diabetes Prevention Program (DPP) lifestyle intervention
Number of subjects: 89
Study 23985436 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 1.5% arginine and 1450 ppm fluoride
Number of subjects: 331
Study 23985436 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice containing 1450 ppm fluoride (positive control)
Number of subjects: 331
Study 20598453 — intervention group
Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 120
Study 20598453 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endocrine therapy and external‐beam radiotherapy
Number of subjects: 120
Study 18669565 — intervention group
Group type: EXPERIMENTAL
Intervention: Open access articles
Number of subjects: 1619
Study 18669565 — intervention group
Group type: COMPARATOR
Intervention: Subscription access articles
Number of subjects: 1619
Study 16630091 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium l-lactate (504 mg elemental magnesium daily)
Number of subjects: 0
Study 16630091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 14681282 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (12.5 mg zinc sulphate daily for 6 days a week for 6 months)
Number of subjects: 709
Study 14681282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 709
Study 10618281 — intervention group
Group type: EXPERIMENTAL
Intervention: ANA enzyme immunoassay (EIA)
Number of subjects: 460
Study 10618281 — intervention group
Group type: EXPERIMENTAL
Intervention: Rat liver and HEp-2
Number of subjects: 460
Study 10618281 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-ENA EIA
Number of subjects: 460
Study 10618281 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-dsDNA EIA
Number of subjects: 460
Study 10618281 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of anti-Scl-70 and anti-Jo-1
Number of subjects: 460
Study 10618281 — intervention group
Group type: COMPARATOR
Intervention: ANA EIA
Number of subjects: 460
Study 8790093 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 61
Study 8790093 — intervention group
Group type: COMPARATOR
Intervention: Control (no cryotherapy)
Number of subjects: 61
Study 8790093 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial RD not involving the fovea
Number of subjects: 61
Study 8790093 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial RD involving the fovea
Number of subjects: 61
Study 8790093 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall visual acuity
Number of subjects: 61
Study 8790093 — intervention group
Group type: EXPERIMENTAL
Intervention: Extent of RD at 3 months
Number of subjects: 61
Study 1636921 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol and metamizole infusion (400 mg tramadol plus 5 g metamizole in 500 ml electrolyte solution)
Number of subjects: 60
Study 1636921 — intervention group
Group type: COMPARATOR
Intervention: Tramadol infusion (400 mg tramadol plus 10 ml placebo in 500 ml electrolyte solution) with ibuprofen suppositories (585.2 mg) preoperatively
Number of subjects: 60
Study 1636921 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol and metamizole infusion
Number of subjects: 60
Study 1636921 — intervention group
Group type: COMPARATOR
Intervention: Tramadol infusion with ibuprofen suppositories
Number of subjects: 60
Study 6199153 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (6 or 12 micrograms/kg/day for 2 weeks)
Number of subjects: 12
Study 31187102 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/mL ketorolac tromethamine
Number of subjects: 60
Study 31187102 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60
Study 29575339 — intervention group
Group type: EXPERIMENTAL
Intervention: Packaged Cognitive Behavior Therapy (PCBT)
Number of subjects: 403
Study 29575339 — intervention group
Group type: EXPERIMENTAL
Intervention: Network Support (NS)
Number of subjects: 403
Study 29575339 — intervention group
Group type: COMPARATOR
Intervention: Case management control treatment
Number of subjects: 403
Study 27144937 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate 20 mg thrice daily for 4 weeks
Number of subjects: 100
Study 27144937 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23124601 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior stabilized mobile TKA
Number of subjects: 69
Study 23124601 — intervention group
Group type: COMPARATOR
Intervention: Posterior stabilized fixed TKA
Number of subjects: 69
Study 23124601 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anterior knee pain
Number of subjects: 69
Study 21699645 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride (0.5 mg/day)
Number of subjects: 8231
Study 21699645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8231
Study 21699645 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 8231
Study 20121500 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 microg/day)
Number of subjects: 166
Study 20121500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 17419222 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-port technique
Number of subjects: 146
Study 17419222 — intervention group
Group type: COMPARATOR
Intervention: Four-port technique
Number of subjects: 146
Study 15540300 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 384
Study 15540300 — intervention group
Group type: COMPARATOR
Intervention: Open resection
Number of subjects: 384
Study 11498726 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) drink
Number of subjects: 0
Study 11498726 — intervention group
Group type: COMPARATOR
Intervention: Balanced amino acid drink (Control)
Number of subjects: 0
Study 9516029 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 750 microg per day
Number of subjects: 10
Study 9516029 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 800 microg per day
Number of subjects: 10
Study 9516029 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 375 microg per day
Number of subjects: 10
Study 9516029 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 400 microg per day
Number of subjects: 10
Study 9516029 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 10
Study 8062327 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa‐2b 3 million units three times a week for 24 weeks
Number of subjects: 160
Study 8062327 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 160
Study 8062327 — intervention group
Group type: EXPERIMENTAL
Intervention: Responders (patients with improvement in serum alanine aminotransferase levels)
Number of subjects: 160
Study 2920584 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (100 mg)
Number of subjects: 96
Study 2920584 — intervention group
Group type: COMPARATOR
Intervention: Physiologic saline solution (Control)
Number of subjects: 96
Study 807867 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 26
Study 31331782 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective Nodal Radiotherapy (ENRT)
Number of subjects: 506
Study 31331782 — intervention group
Group type: COMPARATOR
Intervention: Stereotactic Body Radiotherapy (SBRT)
Number of subjects: 506
Study 27189038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (Zn)
Number of subjects: 2400
Study 27189038 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins (MV)
Number of subjects: 2400
Study 27189038 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc and Multivitamins (Zn + MV)
Number of subjects: 2400
Study 27189038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2400
Study 27189038 — intervention group
Group type: COMPARATOR
Intervention: Zinc vs No Zinc
Number of subjects: 2400
Study 27189038 — intervention group
Group type: COMPARATOR
Intervention: Multivitamins vs No Multivitamins
Number of subjects: 2400
Study 27189038 — intervention group
Group type: COMPARATOR
Intervention: Treatment arms comparison
Number of subjects: 2400
Study 25881614 — intervention group
Group type: EXPERIMENTAL
Intervention: DRV/r once-daily (800/100 mg)
Number of subjects: 60
Study 25881614 — intervention group
Group type: COMPARATOR
Intervention: DRV/r twice-daily (600/100 mg)
Number of subjects: 60
Study 23809446 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.0‐μg/h fentanyl patch for 72 hours
Number of subjects: 60
Study 23809446 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch and an infusion of 2.5‐mg/mL bupivacaine in a subacromial manner for 72 hours
Number of subjects: 60
Study 22073764 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief self-report measure of positive and negative core beliefs about God
Number of subjects: 0
Study 18978485 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole 24-hour prolonged release
Number of subjects: 0
Study 18978485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15720929 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit plus risk feedback
Number of subjects: 30345
Study 15720929 — intervention group
Group type: COMPARATOR
Intervention: Audit only feedback
Number of subjects: 30345
Study 15720929 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30345
Study 11883990 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning to control SCPs
Number of subjects: 0
Study 11883990 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of SCPs
Number of subjects: 0
Study 11883990 — intervention group
Group type: EXPERIMENTAL
Intervention: Control of SCPs
Number of subjects: 0
Study 9470102 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead Intervention program for lead reduction
Number of subjects: 65
Study 9470102 — intervention group
Group type: COMPARATOR
Intervention: Accident Intervention program
Number of subjects: 65
Study 8561982 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV vaccine trial participation
Number of subjects: 0
Study 2131262 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional fiberendoscopy
Number of subjects: 0
Study 2131262 — intervention group
Group type: COMPARATOR
Intervention: Videoendoscopy
Number of subjects: 0
Study 350264 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol drops 4%
Number of subjects: 12
Study 350264 — intervention group
Group type: COMPARATOR
Intervention: Atenolol-then-adrenaline
Number of subjects: 12
Study 350264 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline drops 1%
Number of subjects: 12
Study 350264 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol alone
Number of subjects: 12
Study 350264 — intervention group
Group type: COMPARATOR
Intervention: Combination of atenolol and adrenaline
Number of subjects: 12
Study 30921609 — intervention group
Group type: COMPARATOR
Intervention: Transcranial alternating current stimulation (tACS) at 4 Hz or 30 Hz based on EEG analysis, 5 days/week for 2 weeks followed by physical therapy.
Number of subjects: 0
Study 30921609 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial alternating current stimulation (tACS)
Number of subjects: 0
Study 28599662 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptamen® AF (modified enteral diet rich in proteins, medium chain triglycerides, and fish oil)
Number of subjects: 90
Study 28599662 — intervention group
Group type: COMPARATOR
Intervention: Isosource® Energy (standard diet)
Number of subjects: 90
Study 28599662 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptamen® AF
Number of subjects: 90
Study 28599662 — intervention group
Group type: COMPARATOR
Intervention: Isosource® Energy
Number of subjects: 90
Study 28599662 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhea
Number of subjects: 90
Study 26152940 — intervention group
Group type: EXPERIMENTAL
Intervention: Ophthalmic solution containing an allergen (CPT)
Number of subjects: 159
Study 26152940 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 159
Study 23550857 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg sublingual misoprostol
Number of subjects: 104
Study 23550857 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 IU i.m. oxytocin
Number of subjects: 104
Study 23550857 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 104
Study 21860356 — intervention group
Group type: EXPERIMENTAL
Intervention: HSV-2 infection
Number of subjects: 1836
Study 21860356 — intervention group
Group type: COMPARATOR
Intervention: HSV-2 infection in placebo recipients
Number of subjects: 1836
Study 21860356 — intervention group
Group type: EXPERIMENTAL
Intervention: Past HSV-2 infection
Number of subjects: 1836
Study 19249425 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus coumarin (adjunctive anticoagulation)
Number of subjects: 251
Study 19249425 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (control)
Number of subjects: 251
Study 17188780 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 96
Study 17188780 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 96
Study 15492433 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide-erythromycin gel
Number of subjects: 56
Study 15492433 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole gel
Number of subjects: 56
Study 11560210 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravenously for 72 hours
Number of subjects: 21
Study 11560210 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone
Number of subjects: 21